Jiayin Yang

1.4k total citations
68 papers, 861 citations indexed

About

Jiayin Yang is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Jiayin Yang has authored 68 papers receiving a total of 861 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 23 papers in Oncology and 21 papers in Surgery. Recurrent topics in Jiayin Yang's work include Hepatocellular Carcinoma Treatment and Prognosis (12 papers), RNA modifications and cancer (11 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (10 papers). Jiayin Yang is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (12 papers), RNA modifications and cancer (11 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (10 papers). Jiayin Yang collaborates with scholars based in China, United States and Argentina. Jiayin Yang's co-authors include Tao Lv, Yujun Shi, Lvnan Yan, Yongjie Zhou, Lünan Yan, Tianfu Wen, Hong Bu, Bo Li, Mingqing Xu and Wei Peng and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Jiayin Yang

62 papers receiving 857 citations

Peers

Jiayin Yang
Jiayin Yang
Citations per year, relative to Jiayin Yang Jiayin Yang (= 1×) peers Hengjun Gao

Countries citing papers authored by Jiayin Yang

Since Specialization
Citations

This map shows the geographic impact of Jiayin Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiayin Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiayin Yang more than expected).

Fields of papers citing papers by Jiayin Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiayin Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiayin Yang. The network helps show where Jiayin Yang may publish in the future.

Co-authorship network of co-authors of Jiayin Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Jiayin Yang. A scholar is included among the top collaborators of Jiayin Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiayin Yang. Jiayin Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Jie, Yongjie Zhou, Xi Xu, et al.. (2025). RBM39 promotes hepatocarcinogenesis by regulating RFX1’s alternative splicing and subsequent activation of integrin signaling pathway. Oncogene. 44(20). 1488–1503. 2 indexed citations
2.
Jiang, Lan, Zhenru Wu, Shiyu Liu, et al.. (2025). c-Kit+ cells that intercalate with crypt Lgr5+ cells are distinctively multipotent in colonic epithelium renewal and repair. Cell Death and Differentiation. 32(7). 1244–1258.
3.
Wei, Xinyu, Wen Wen, Lingxiao Yang, et al.. (2025). Stem Cell‐Derived Exosomes as Nanotherapeutics for Inflammatory Diseases. SHILAP Revista de lepidopterología. 4(1). 3 indexed citations
4.
Xu, Gang, Bao Jin, Xueshuai Wan, et al.. (2024). Novel multifactor predictive model for postoperative survival in gallbladder cancer: a multi-center study. World Journal of Surgical Oncology. 22(1). 263–263.
5.
Yang, Jiayin, et al.. (2024). CIB315: An Allogeneic, Off-the-Shelf Anti-GPRC5D iPSC-Derived CAR-NK Product Targeting Multiple Myeloma. Blood. 144(Supplement 1). 2055–2055. 5 indexed citations
7.
Hu, Xin, Guanrong Chen, Qiyang Cheng, et al.. (2024). Integrated Multiomics Reveals Silencing of has_circ_0006646 Promotes TRIM21‐Mediated NCL Ubiquitination to Inhibit Hepatocellular Carcinoma Metastasis. Advanced Science. 11(16). e2306915–e2306915. 14 indexed citations
9.
Lv, Tao, et al.. (2023). USP35 promotes hepatocellular carcinoma progression by protecting PKM2 from ubiquitination‑mediated degradation. International Journal of Oncology. 63(4). 15 indexed citations
10.
Zheng, Daofeng, et al.. (2022). SIRT5 alleviates hepatic ischemia and reperfusion injury by diminishing oxidative stress and inflammation via elevating SOD1 and IDH2 expression. Experimental Cell Research. 419(2). 113319–113319. 15 indexed citations
11.
Yuan, Jingsheng, Zijian Liu, Zhenru Wu, Jiayin Yang, & Tao Lv. (2022). Comprehensive Molecular Analysis Identified an SRSF Family-Based Score for Prognosis and Therapy Efficiency Prediction in Hepatocellular Carcinoma. Cancers. 14(19). 4727–4727. 4 indexed citations
12.
Yuan, Jingsheng, Tao Lv, Jian Yang, et al.. (2022). The lipid transporter HDLBP promotes hepatocellular carcinoma metastasis through BRAF-dependent epithelial-mesenchymal transition. Cancer Letters. 549. 215921–215921. 19 indexed citations
13.
Zheng, Daofeng, et al.. (2022). Overexpression of transcription factor 3 drives hepatocarcinoma development by enhancing cell proliferation via activating Wnt signaling pathway. Hepatobiliary & pancreatic diseases international. 21(4). 378–386. 7 indexed citations
14.
Zhou, Yongjie, Yuwei Chen, Xiaoyun Zhang, et al.. (2021). Brahma‐Related Gene 1 Inhibition Prevents Liver Fibrosis and Cholangiocarcinoma by Attenuating Progenitor Expansion. Hepatology. 74(2). 797–815. 25 indexed citations
15.
Yang, Jiayin, Fei Guo, Tao Lyu, et al.. (2020). [Research of artificial intelligence-based clinical decision support system for primary hepatocellular carcinoma].. Zhonghua yixue zazhi. 100(48). 3870–3873. 2 indexed citations
16.
Wang, Guoliang, et al.. (2019). PPARα Suppresses PD-L1-Mediated Immune Escape by Down-regulating SPP1 in Human Hepatocellular Carcinoma. Cancer Research and Treatment. 4 indexed citations
17.
Zhou, Yongjie, et al.. (2016). Deletion of interleukin-6 in monocytes/macrophages suppresses the initiation of hepatocellular carcinoma in mice. Journal of Experimental & Clinical Cancer Research. 35(1). 131–131. 118 indexed citations
18.
Peng, Wei, Chuan Li, Tian-Fu Wen, et al.. (2014). Neutrophil to lymphocyte ratio changes predict small hepatocellular carcinoma survival. Journal of Surgical Research. 192(2). 402–408. 72 indexed citations
19.
Zhao, Jichun, L.-N. Yan, Biao Li, et al.. (2009). Diabetes Mellitus After Living Donor Liver Transplantation: Data From Mainland China. Transplantation Proceedings. 41(5). 1756–1760. 14 indexed citations
20.
Chen, Yongbing, Mao-Lin Yan, Lixin Liu, et al.. (2007). Establishment of hepatocellular carcinoma multidrug resistant monoclone cell line HepG2/mdr1. Chinese Medical Journal. 120(8). 703–707. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026